With three new partnerships, 10x Genomics signals a move beyond research tools toward clinical diagnostics using its single-cell and spatial biology platforms.
According to MarketsandMarketstm, the Next-Generation Sequencing Market is projected to grow from about USD 14.94 billion in ...
Veteran genomics leader joins Illumina to advance global medical strategyIllumina chief commercial officer to depart for role as a life science tools company CEO SAN DIEGO, Jan. 8, 2026 /PRNewswire/ ...
Zacks Investment Research on MSN
Three genomics stocks worth tracking this year
An updated edition of the Nov. 18, 2025, article. Genomics is a broad and detailed study of genomes (an organism’s complete set of deoxyribonucleic acid or DNA). Recent scientific advances in this ...
Looking to usher in a more “predictable” year in 2026, Illumina is working with officials in China as it remains on the ...
Jan 13 (Reuters) - Gene sequencing company Illumina on Tuesday introduced a dataset that maps genetic changes to help ...
The company unveiled the appointment alongside news of the departure of its chief commercial officer.
Illumina launched the Billion Cell Atlas to train AI on one billion single cells. AstraZeneca, Merck and Lilly are founding ...
Add Yahoo as a preferred source to see more of our stories on Google. Illumina's headquarters in San Diego. Illumina has named Eric Green as chief medical officer, providing a home to the first ...
Illumina Inc. presented at the J.P. Morgan 2026 Healthcare Conference on Jan. 13 and introduced what it said is the world's largest genome-wide genetic perturbation dataset, being built to accelerate ...
AbbVie struck a big deal to enter the hot PD-1xVEGF bispecific space. | In this week's Asia news recap, AbbVie struck a big ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results